Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination

Infection and Immunity

Volumn 73, Issue 7, 2005, Pages 4070-4080

  Fisseha, Makda ^a,c   Chen, Ping ^a,d   Brandt, Brenda ^a   Kijek, Todd ^a,e   Moran, Elizabeth ^a   Zollinger, Wendell ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b WRAIR   (United States)

^c NESTLÉ RESEARCH CENTER   (Switzerland)

^d SEQUELLA INC   (United States)

^e 121 General Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOOLIGOSACCHARIDE; OUTER MEMBRANE PROTEIN; POLYACRYLAMIDE GEL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DELETION MUTANT; IMMUNOGENICITY; IPXL GENE; IPXL1 GENE; IPXL2 GENE; KNOCKOUT GENE; MEMBRANE VESICLE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SYNX GENE; VACCINATION;

ACYLTRANSFERASES; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CYTOKINES; LIPOPOLYSACCHARIDES; MENINGOCOCCAL VACCINES; MICE; MUTATION; RABBITS; STRUCTURE-ACTIVITY RELATIONSHIP; VACCINATION;

EID: 21544435705     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.7.4070-4080.2005     Document Type: Article

References (48)

1. Bjune, G., E. A. Høiby J. K. Grønnesby, (swsl) O. Arnesen, J. H. Fredriksen, A. Halstensen, E. Holten, A. K. Lindbak, H. Nøkleby, E. Rosenqvist, L. K. Solberg, O. Closs, J. Eng, L. O. Frøholm, A. Lyslad, L. S. Bakketeig, and B. Hareide. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096.
2. Boslego, J., J. Garcia, C. Cruz, W. Zollinger, B. Brandt, S. Ruiz, M. Martinez, J. Arthur, P. Underwood, W. Silva, et al. 1995. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Vaccine 13:821-829.
3. Bruge, J., N. Bouveret-Le Cam, B. Danve, G. Rougon, and D. Schulz. 2004. Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers. Vaccine 22:1087-1096.
4. Cartwright, K., R. Morris, H. Rumke, A. Fox, R. Borrow, N. Begg, P. Richmond, and J. Poolman. 1999. Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins. Vaccine 17:2612-2619.
5. Catlin, B. W. 1973. Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing. J. Infect. Dis. 128:178-194.
6. Clementz, T., J. J. Bednarski, and C. R. Raetz. 1996. Function of the htrB high temperature requirement gene of Escherichia coli in the acylation of lipid A: HtrB catalyzed incorporation of laurate. J. Biol. Chem. 271:12095-12102.
7. Clementz, T., Z. Zhou, and C. R. Raetz. 1997. Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A: acylation by MsbB follows laurate incorporation by HtrB. J. Biol. Chem. 272:10353-10360.
8. Cox, A. D., J. C. Wright, J. Li, D. W. Hood, E. R. Moxon, and J. C. Richards. 2003. Phosphorylation of the lipid A region of meningococcal lipopolysaccharide: identification of a family of transferases that add phosphoethanolamine to lipopolysaccharide. J. Bacteriol. 185:3270-3277.
9. De Moraes, J. C., B. A. Perkins, M. C. C. Camargo, N. T. Hidalgo, H. A. Barbosa, C. T. Sacchi, I. M. Landgraf, V. L. Gattas, G. Vasconcelos Hde, I. M. Gral, V. L. Gattas, H. de G. Vasconcelos, B. D. Plikaytis, J. D. Wenger, and C. V. Broome. 1992. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet 340:1074-1078.
10. Drabick, J. J., B. L. Brandt, E. E. Moran, N. B. Saunders, D. R. Shoemaker, and W. D. Zollinger. 1999. Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers. Vaccine 18:160-172.
11. Ellis, C. D., B. Lindner, C. M. Anjam Khan, U. Zahringer, R. Demarco de Hormaeche. 2001. The Neisseria gonorrhoeae lpxLII gene encodes for a late-functioning lauroyl acyl transferase, and a null mutation within the gene has a significant effect on the induction of acute inflammatory responses. Mol. Microbiol. 42:167-181.
12. Finne, J., M. Leinenen, and P. H. Makela. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet ii:355-357.
13. Guthrie, T., S. Y. Wong, B. Liang, L. Hyland, S. Hou, E. A. Hoiby, and S. R. Andersen. 2004. Local and systemic antibody responses in mice immunized intranasally with native and detergent-extracted outer membrane vesicles from Neisseria meningitidis. Infect. Immun. 72:2528-2537.
14. Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580.
15. Haneberg, B., R. Dalseg, E. Wedege, E. A. Hoiby, I. L. Haugen, F. Oftung, S. R. Andersen, L. M. Naess, A. Aase, T. E. Michaelsen, and J. Holst. 1998. Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans. Infect. Immun. 66:1334-1341.
16. Ingalls, R. R., E. Lien, and D. T. Golenbock. 2001. Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through Toll-like receptor 2. Infect. Immun. 69:2230-2236.
17. Jones, B. D., W. A. Nichols, B. W. Gibson, M. G. Sunshine, and M. A. Apicella. 1997. Study of the role of the htrB gene in Salmonella typhimurium virulence. Infect. Immun. 65:4778-4783.
18. Karkhanis, Y. D., J. Y. Zeltner, J. J. Jackson, and D. J. Carlo. 1978. A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of gram-negative bacteria. Anal. Biochem. 85:595-601.
19. Karow, M., O. Fayet, A. Cegielska, T. Ziegelhoffer, and C. Georgopoulos. 1991. Isolation and characterization of the Escherichia coli htrB gene, whose product is essential for bacterial viability above 33°C in rich media. J. Bacteriol. 173:741-750.
20. Karow, M., and C. Georgopoulos. 1992. Isolation and characterization of the Escherichia coli msbB gene, a multicopy suppressor of null mutations in the high-temperature requirement gene htrB. J. Bacteriol. 174:702-710.
21. Katial, R. K., B. L. Brandt, E. E. Moran, S. Marks, V. Agnello, and W. D. Zollinger. 2002. Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine. Infect. Immun. 70: 702-707.
22. Kotani, S., and H. Takada. 1990. Structural requirements of lipid A for endotoxicity and other biological activities: an overview. Adv. Exp. Med. Biol. 256:13-43.
23. Kulshin, V. A., U. Zahringer, B. Lindner, C. E. Frasch, C. M. Tsai, B. A. Dmitriev, and E. T. Rietschel. 1992. Structural characterization of the lipid A component of pathogenic Neisseria meningitidis. J. Bacteriol. 174:1793-1800.
24. Lee, N. G., M. G. Sunshine, J. J. Engstrom, B. W. Gibson, and M. A. Apicella. 1995. Mutation of the htrB locus of Haemophilus influenzae non-typeable strain 2019 is associated with modifications of lipid A and phosphorylation of the lipo-oligosaccharide. J. Biol. Chem. 270:27151-27159.
25. Low, K. B., M. Ittensohn, T. Le, J. Platt, S. Sodi, M. Amoss, O. Ash, E. Carmichael, A. Chakraborty, J. Fischer, S. L. Lin, X. Luo, S. I. Miller, L. Zheng, I. King, J. M. Pawelek, and D. Bermudes. 1999. Lipid A mutant Salmonella with suppressed virulence and TNF-α induction retain tumor-targeting in vivo. Nat. Biotechnol. 17:37-41.
26. Moran, E. E., B. L. Brandt, and W. D. Zollinger. 1994. Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity. Infect. Immun. 62:5290-5295.
27. Murray, S. R., D. Bermudes, K. S. de Felipe, and K. B. Low. Extragenic suppressors of growth defects in msbB Salmonella. J. Bacteriol. 183:5554-5561, 2001.
28. Nichols, W. A. C. R. H. Raetz T. Clementz A. L. Smith J. A. Hanson M. R. Ketterer M. Sunshine, and M. A. Apicella. 1997. htrB of Haemophilus influenzae: determination of biochemical activity and effects on virulence and lipooligosaccharide toxicity. J. Endotoxin Res. 4:163-172.
29. Nikaido, H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67:593-656.
30. Peeters, C. C., H. C. Rumke, L. C. Sundermann, E. M. Rouppe van der Voort, J. Meulenbelt, M. Schuller, A. J. Kuipers, P. van der Ley, and J. T. Poolman. 1996. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 14:1009-1015.
31. Post, D. M., M. R. Ketterer, N. J. Phillips, B. W. Gibson, and M. A. Apicella. 2003. The msbB mutant of Neisseria meningitidis strain NMB has a defect in lipooligosaccharide assembly and transport to the outer membrane. Infect. Immun. 71:647-655.
32. Reitschel, E. T., L. Brade, U. Schade, U. Seydel, U. Zahringer, K. Brandenburg, I. Helander, O. Holst, S. Kondo, H. M. Kuhn, B. Lindner, E. Rohrscheidt, R. Russa, H. Labischinski, D. Naumann, and H. Brade. 1990. Bacterial lipopolysaccharide: relationship of structure and conformation to endotoxic activity, serological specificity, and biological function, p. 81-99. In N. Black, I. R. Cohen, D. Kritchevsky, A. Lajtha, and R. Paoletti (ed.), Advances in experimental medicine and biology. Kluwer Academic Publishers, New York, N.Y.
33. Salisbury, D. 2001. Introduction of a conjugate meningococcal type C vaccine programme in the UK. J. Paediatr. Child Health 37:S34-S36.
34. Sambrook, J., E. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring harbor Laboratory Press, Cold Spring Harbor, N.Y.
35. Saunders, N. B., D. R. Shoemaker, B. L. Brandt, E. E. Moran, T. Larsen, and W. D. Zollinger. 1999. Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice. Infect. Immun. 67:113-119.
36. Saunders, N. B., D. R. Shoemaker, B. L. Brandt, and W. D. Zollinger. 1997. Confirmation of suspicious cases of meningococcal meningitis by PCR and enzyme-linked immunosorbent assay. J. Clin. Microbiol. 35:3215-3219.
37. Schneider, H., C. A. Hammack, M. A. Apicella, and J. M. Griffiss. 1988. Instability of expression of lipooligosaccharides and their epitopes in Neisseria gonorrhoeae. Infect. Immun. 56:942-946.
38. Sierra, G. V., H. C. Campa, N. M. Varcacel, I. L. Garcia, P. L. Izquierdo, P. F. Sotolongo, G. V. Casanueva, C. O. Rico, C. R. Rodriguez, and M. H. Terry. 1991. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14:195-207.
39. Snyder, D. S., and T. J. McIntosh. 2000. The lipopolysaccharide barrier: correlation of antibiotic susceptibility with antibiotic permeability and fluorescent probe binding kinetics. Biochemistry 39:11777-11787.
40. Swartley, J. S., C. F. McAllister, R. A. Hajjeh, D. W. Heinrich, and D. S. Stephens. 1993. Deletions of Tn916-like transposons are implicated in tetM-mediated resistance in pathogenic Neisseria. Mol. Microbiol. 10:299-310.
41. Tappero, J. W., R. Lagos, A. M. Ballesteros, B. Plikaytis, D. Williams, J. Dykes, L. L. Gheesling, G. M. Carlone, E. A. Hoiby, J. Holst, H. Nokleby, E. Rosenqvist, G. Sierra, C. Campa, F. Sotolongo, J. Vega, J. Garcia, P. Herrera, J. T. Poolman, and B. A. Perkins. 1999. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA 281:1520-1527.
42. Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.
43. van der Ley, P., L. Steeghs, H. J. Hamstra, J. ten Hove, B. Zomer, and L. van Alphen. 2001. Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect. Immun. 69:5981-5990.
44. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure. Methods Carbohydr. Chem. 5:83-91.
45. Wyle, F. A., M. S. Artenstein, B. L. Brandt, E. C. Tramont, D. L. Kasper, P. L. Altieri, S. L. Berman, and J. P. Lowenthal. 1972. Immunologic response of man to group B meningococcal polysaccharide vaccines. J. Infect. Dis. 126:514-521.
46. Yamamoto, A., T. Sakai, M. Ochiai, K. Kamachi, M. Kataoka, H. Toyoizumi, and Y. Horiuchi. 2003. A cell line assay system for predicting the response of human blood to endotoxin. Jpn. J. Infect. Dis. 56:93-100.
47. Zollinger, W. D., and J. W. Boslego. 1981. A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies. J. Immunol. Methods 46:129-140.
48. Zollinger, W. D., D. R. Shoemaker, A. G. Saunders, and B. L. Brandt. May 2003. Vaccine against gram-negative bacteria. U.S. patent 6,558,677 B2.